The disclosed technique relates to implantable cardioverter defibrillators, in general, and to capacitor configurations and arrangements for flexible subcutaneous implantable cardioverter defibrillators, in particular.
An implantable cardioverter-defibrillator (herein abbreviated ICD) is a medical device combining a cardioverter and a defibrillator into a single implantable unit. An ICD is thus a small battery-powered electrical impulse generator that is implanted in patients who are at risk of sudden cardiac death due to ventricular fibrillation (which can be remedied via defibrillation) and ventricular tachycardia (which can be remedied via cardioversion). As both defibrillation and cardioversion require significant amounts of energy to be delivered to the heart in order to be effective, an ICD usually requires a plurality of high energy capacitors in order to store sufficient energy per electrical impulse to be delivered by the ICD to a patient suffering from ventricular fibrillation (herein abbreviated VF) or ventricular tachycardia (herein abbreviated VT).
One kind of known ICD is implanted intravascularly or intracardially, having leads positioned within the heart as well as being attached to the outer surface of the heart. The leads are substantially electrodes capable of providing high voltage electrical impulses to the heart. Such ICDs require the plurality of high energy capacitors to provide about 35 40 joules of energy per electrical impulse, as well as having a high voltage per electrical impulse in the range of 700 800 volts to properly defibrillate, for example, a patient suffering from VF. Another kind of known ICD is implanted subcutaneously and includes leads that are placed under the skin and without direct contact with the heart. Such ICDs are also known in the art as subcutaneous ICDs. The electrical impulse in a subcutaneous ICD needs to pass through muscles, the lungs and bones to defibrillate the heart as the leads are placed subcutaneously and are not in contact with the heart. As such, subcutaneous ICDs must employ even higher energy and voltage levels than intracardiac ICDs. For example, the only currently marketed available subcutaneous ICD, produced by Boston Scientific and sold under the brand name Emblem™ S-ICD System, generates approximately 80 joules and 1000 volts per electrical impulse. Either way however, both an intracardiac ICD and a subcutaneous ICD require a plurality of high energy capacitors that can store the requisite levels of energy and can support the required voltages per electrical impulse.
Wet tantalum capacitors are used in most state of the art ICDs. Such capacitors are used due to their ability to store high energy levels as well as their ability to maintain high voltages, and thus have a high volumetric efficiency. Most ICDs, including the Emblem™ S-ICD System, have a can and leads design. In such ICDs the capacitors are stored in the can and are therefore shaped, designed and built to accommodate the shape of the can. The most common capacitor shape used in ICDs is in the form of a half circle or a shape similar or close to a half circle, also known as a ‘D shape’. Reference is now made to
One of the challenges in building capacitors for ICDs and subcutaneous ICDs is energy efficiency per volume. On the one hand, substantial amounts of energy are required for ICDs, and even more so for subcutaneous ICDs to function effectively. There is thus a desire to use larger sized capacitors to meet these requirements. However in contradistinction, since ICDs and subcutaneous ICDs are implanted in a patient, there is a desire to make such devices as small and as unobtrusive as possible. All currently marketed ICDs use capacitors to store and provide energy for electrical impulses, such as wet tantalum capacitor 10. Such capacitors enable an appropriate energy efficiency per volume to be achieved while also meeting both the energy and voltage requirements of ICDs and subcutaneous ICDs, together with the shape and volume constraints of such devices. Capacitor shapes and designs for ICDs and subcutaneous ICDs are known in the art and are described in the following patents: U.S. Pat. No. 5,749,911 to Westlund, U.S. Pat. No. 7,715,174 to Beauvais et al. and U.S. Pat. No. 7,656,646 to Sherwood.
The configuration, shape and design of wet tantalum capacitor 10 as shown in
The disclosed technique overcomes the disadvantages of the prior art by providing a novel capacitor arrangement and configuration for use in a subcutaneous ICD. According to a first embodiment of the disclosed technique, there is thus provided a capacitor configuration for use in a subcutaneous implantable cardioverter defibrillator having a tubular shape. The capacitor configuration comprises a first plurality of high volumetric efficiency capacitors. Each one of the high volumetric efficiency capacitors has a disc shape. The high volumetric efficiency capacitors are coupled in parallel and are arranged in a stack as a first array of capacitors, thereby forming a cylindrically shaped capacitor.
According to a second embodiment of the disclosed technique, the capacitor configuration further comprises a second plurality of high volumetric efficiency capacitors. The second plurality of high volumetric efficiency capacitors are coupled in parallel and are arranged in a stack as a second array of capacitors. The first array of capacitors is coupled in series with the second array of capacitors.
The disclosed technique will be understood and appreciated more fully from the following detailed description taken in conjunction with the drawings in which:
The disclosed technique overcomes the disadvantages of the prior art by providing a novel high energy capacitor configuration for a flexible subcutaneous ICD that achieves the energy and voltage requirements for a subcutaneous ICD while also conforming to volume and shape constraints of a tubular shaped device for subcutaneous implantation. The novel capacitor configuration is also suitable for an implantable subcutaneous string heart device as mentioned above. The high energy capacitor configuration can further be used for a wet tantalum capacitor configuration exhibiting a cylindrical shape suitable to be inserted into a flexible tubular structure such as the ISSD of NewPace Ltd. The ISSD is a flexible and unitary subcutaneous ICD which is implanted under the skin of a patient and delivers electrical impulses with characteristics similar to a subcutaneous ICD. As mentioned above, the ISSD is also a flexible and tubular structure, which requires higher energy and voltage per electrical impulse as compared to intravascular and intracardiac ICDs, since the ISSD is a subcutaneous ICD and the electrical impulse energy needs to cross more tissue, muscles and bone before reaching the heart.
According to the disclosed technique, a wet tantalum capacitor is formed in the shape of a disc, coin or ellipse, conforming to the volume and shape of the ISSD lengthwise. The disc or coin shape may be circular in cross section or elliptical in cross section. A plurality of capacitors can thus be coupled in parallel, forming a capacitor array which conforms to the volume and shape of the ISSD lengthwise. A plurality of capacitor arrays can be coupled in series giving a capacitor configuration, thereby delivering sufficient energy and voltage per electrical impulse while conforming to the shape and volume of the ISSD lengthwise. As each capacitor array is coupled with another capacitor array, a degree of flexibility is enabled between capacitor arrays. The capacitor configuration according to the disclosed technique is capable of delivering the requisite amounts of voltage and energy to sufficiently defibrillate the heart of a patient with leads that are located under the skin and not within the heart or the vascular system. Furthermore, such a capacitor configuration may be integrated into a tubular and flexible device with a limited outer diameter and length for each capacitor.
In general, it is a challenge to squeeze high energy capacitors, such as wet tantalum capacitors, into a small cylindrical shape, as required for a flexible and tubular device such as the ISSD of NewPace Ltd. As described above, most prior art ICDs and even prior art subcutaneous ICDs utilize flat, semi-circle or ‘D shaped’ capacitors to meet energy and voltage requirements while also satisfying the spatial requirements of such devices. According to the disclosed technique, due to the round, elliptical shape of the ISSD of NewPace Ltd., a novel capacitor configuration was required which needed to have a generally cylindrical shape to match the shape of the ISSD of NewPace Ltd. while also providing sufficient energy and voltage as required for a subcutaneous ICD, which as mentioned above is about 70 80 joules and around 1100-1200 volts. It is noted that the energy and voltage requirements for a subcutaneous ICD such as the ISSD may be slightly lower, such as 50 joules and 1000 volts, however these requirements are nonetheless higher than the requirements for an intracardiac ICD.
Reference is now made to
Reference is now made to
Reference is now made to
Reference is now made to
A second capacitor configuration 172 is shown which includes a plurality of anodes 174A, 174B, 174C and 174D and a respective plurality of cathodes (not shown). Plurality of anodes 174-174D together forms a cylindrical shape 175. Plurality of anodes 174-174D is arranged widthwise as elongated anodes, similar to first capacitor configuration 171. Second capacitor configuration 172 also forms part of the prior art and also does not meet the energy and voltage requirements for a subcutaneous ICD while also meeting the volume and shape constraints of a flexible tubular device as mentioned above due to the increased distance between any point in one of the anodes to any point in its respective cathode. The increased distance causes an increase in ESR thereby not enabling sufficient energy and voltage to be stored in such a capacitor configuration while nonetheless keeping its overall size and volume to a minimum.
A third capacitor configuration 180 is shown which includes a plurality of anodes 1821, 1822, 1823, 1824 and 182N and a respective plurality of cathodes (not shown). Plurality of anodes 1821-182N together forms a cylindrical shape 184. Plurality of anodes 1821-182N is arranged lengthwise, thus forming a stack of flat, disc-shaped capacitors. As the inventors have discovered, such a configuration minimizes the ESR in a capacitor configuration, thereby enabling the requisite energy and voltage (approximately 70 80 joules and 1200 volts) for a subcutaneous ICD. In addition, such a capacitor configuration meets the size, shape and volume constraints of a flexible, tubular device to be implanted subcutaneously and function as an ICD, such as the ISSD as mentioned above. It is noted that plurality of anodes 1821182N can also be a plurality of capacitors (not shown).
As described above, in the case of a subcutaneous ICD where significant energy and voltage is required, the cylindrical anode of first capacitor configuration 171 as well as the split elongated anode structure of second capacitor configuration 172 do not meet the requirements of energy and voltage while also meeting the spatial requirements of flexible, tubular structure. In general, long dual anode or multiple anode wet tantalum capacitors in cylindrical shape (such as shown in first and second capacitor configurations 171 and 172) are technically challenging and usually do not meet the high energy requirements for a subcutaneous ICD in a small volume, as is desired in a subcutaneous ICD. The increase in ESR in such capacitor configurations causes a significant reduction in energy and voltage per volume as compared with third capacitor configuration 180. Whereas this reduction in energy and voltage per volume can be compensated for by elongating the anodes, the resultant anodes and capacitors will not meet the spatial requirements of a subcutaneous ICD to be implanted under the skin of a patient around his heart. Such anodes and capacitors will be either too thick to be implanted subcutaneously, bulging out of the skin of the patient and being uncomfortable as well as not aesthetically pleasing or too long to be implanted subcutaneously in a patient in a noninvasive manner.
Reference is now made to
Reference is now made to
It will be appreciated by persons skilled in the art that the disclosed technique is not limited to what has been particularly shown and described hereinabove. Rather the scope of the disclosed technique is defined only by the claims, which follow.
This application claims the benefit of, and priority to, U.S. Provisional Application Ser. No. 62/034,804, filed Aug. 8, 2014, U.S. Provisional Application Ser. No. 62/201,595, filed Aug. 6, 2015, and U.S. Provisional Application Ser. No. 62/201,609, filed Aug. 6, 2015, the contents of each of which is hereby incorporated by reference in their entirety.
Number | Date | Country | |
---|---|---|---|
62201595 | Aug 2015 | US | |
62201609 | Aug 2015 | US | |
62034804 | Aug 2014 | US |